نتایج جستجو برای: rivastigmine hydrogen tartrate

تعداد نتایج: 149061  

2011
Sit Foon Cheng Seik Weng Ng

In the title hydrated molecular salt, C(12)H(9)N(2) (+)·C(4)H(5)O(6) (-)·2H(2)O, the cation is almost planar (r.m.s. deviation = 0.014 Å); the carbon skeleton of the anion assumes a trans conformation [C-C-C-C torsion angle = -179.86 (14)°]. The carboxyl end of one hydrogen tartrate anion forms a short hydrogen bond to the carboxyl-ate end of another anion [O⋯O = 2.508 (2) Å] in a head-to-tail ...

Journal: :BMC Geriatrics 2005
Martin R Farlow Mary L Lilly

BACKGROUND Rivastigmine, a butyl- and acetylcholinesterase inhibitor, is approved for symptomatic treatment of Alzheimer's disease (AD). Data supporting the safety and efficacy of second-generation cholinesterase inhibitors, such as rivastigmine, are available for treatment up to 1 year, with limited data up to 2 1/2 years. The purpose of this report is to present safety and effectiveness data ...

2010
Hou-Ting Liu Jing Lu Da-Qi Wang

In the title compound, {[Zn(C(4)H(4)O(6))(H(2)O)]·2H(2)O}(n), the l-tartrate ligands adopt μ(4)- and μ(2)-coordination modes. The Zn(II) atom adopts an octa-hedral geometry and is chelated by two kinds of l-tartrate ligands through the hydr-oxy and carboxyl-ate groups and coordinated by one unchelating carboxyl-ate O atom and one water mol-ecule. In the crystal, the l-tartrate ligands link the ...

2017
Gaetano Perrotta Guillaume Bonnier Djalel‐Eddine Meskaldji David Romascano Ruslan Aydarkhanov Alessandro Daducci Samanta Simioni Matthias Cavassini Melanie Metral François Lazeyras Reto Meuli Gunnar Krueger Renaud A. Du Pasquier Cristina Granziera

Rivastigmine has been shown to improve cognition in HIV+ patients with minor neurocognitive disorders; however, the mechanisms underlying such beneficial effect are currently unknown. To assess whether rivastigmine therapy is associated with decreased brain inflammation and damage, we performed T1/T2* relaxometry and magnetization transfer imaging in 17 aviremic HIV+ patients with minor neuroco...

Journal: :Alcohol and alcoholism 2008
Han J Luykx Lucille D A Dorresteijn P M Judith Haffmans Annette Bonebakker Margreet Kerkmeer Vincent M Hendriks

AIMS To evaluate whether rivastigmine, an achetylcholinesterase inhibitor (AChEl), may be effective in restoring memory in Wernicke-Korsakoff's syndrome (WKS). METHODS Five patients treated with rivastigmine for a period of 6 months were compared with five matched control patients, who received 6 months' conventional treatment, but without rivastigmine. Memory tests were administered at basel...

2008
Liu Shi-Zhu

In the title polymer, {[La(2)(C(4)H(4)O(6))(3)(H(2)O)(3)]·2H(2)O}(n), two symmetry-independent La(III) ions are nine-coordinated and display a distorted monocapped square-anti-prismatic geometry. One is coordinated by seven O atoms from four tartrate ligands and two water mol-ecules, the other by eight O atoms from five tartrate ligands and one water mol-ecule. The three tartrate ligands in the...

Journal: :Expert opinion on drug metabolism & toxicology 2006
M Asif A Siddiqui Antona J Wagstaff

Rivastigmine is a carbamate-type dual inhibitor of brain acetyl- and butyrylcholinesterases that has been evaluated in the symptomatic treatment of patients with mild to moderate dementia associated with idiopathic Parkinson's disease. Oral rivastigmine 3-12 mg/day for 24 weeks was significantly more effective than placebo in ameliorating cognitive and functional decline, including attentional ...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه سیستان و بلوچستان 1390

abstract the influence of cation?? and anion?? interactions on the strength and nature of n…h hydrogen bond has been investigated by quantum chemical calculations in s-triazine…3hf complex. ab initio calculations were performed at mp2/6-311++g(d,p) level of theory. the natural bond orbital (nbo) analysis and the bader’s quantum theory of atoms in molecules (aim) were also used to elucidate t...

Journal: :The Lancet. Neurology 2007
Howard H Feldman Steven Ferris Bengt Winblad Nikolaos Sfikas Linda Mancione Yunsheng He Sibel Tekin Alistair Burns Jeffrey Cummings Teodoro del Ser Domenico Inzitari Jean-Marc Orgogozo Heinrich Sauer Philip Scheltens Elio Scarpini Nathan Herrmann Martin Farlow Steven Potkin H Cecil Charles Nick C Fox Roger Lane

OBJECTIVE To assess the effect of rivastigmine in patients with mild cognitive impairment (MCI) on the time to clinical diagnosis of Alzheimer's disease (AD) and the rate of cognitive decline. METHODS The study was a double-blind, randomised, placebo-controlled trial of up to 48 months. All patients had MCI operationally defined by having cognitive symptoms, a global clinical dementia rating ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید